Compare CDW Corp. (CDW) vs UnitedHealth Group Inc (UNH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
CDW Corp. vs UnitedHealth Group Inc — how do they compare? CDW Corp. trades at $139.35 (market cap $17.81B), while UnitedHealth Group Inc trades at $416.67 (market cap $389.68B). The key difference: UnitedHealth Group Inc is far larger — about 21.9× CDW Corp.'s market cap, and UnitedHealth Group Inc pays the higher dividend (2.16%). Which is the better fit depends on your goals.
| CDW | UNH | |
|---|---|---|
Market Cap | $17.81B | $389.68B |
Sector | Technology | Health |
52-Week High | $182.18 | $431.68 |
52-Week Low | $99.30 | $237.77 |
Enterprise Value | $23.02B | $436.36B |
Dividend Yield | 1.81% | 2.16% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
CDW trades at $144.36, down slightly by 0.02% today, with a bullish technical outlook supported by moving averages and a consensus analyst price target of $145.83. The company reported Q1 2026 earnings that met expectations with $2.28 EPS, following beats in previous quarters. Revenue for 2025 was $22.42B with a net income margin of 4.7%, while valuation metrics show a P/E of 17.58 and P/S of 0.83. Recent news highlights AI infrastructure demand and a $1B share repurchase authorization.
The outlook for CDW is positive, driven by AI growth opportunities and strong profitability, but risks include margin pressure and competitive threats. Analysts are bullish with 70.59% buy ratings, suggesting potential upside from current levels, though investors should monitor execution on earnings targets and macroeconomic conditions.
UnitedHealth Group (UNH) trades at $425.19, up 0.13% on the day, with a bullish technical outlook supported by moving averages. The stock shows consistent earnings beats, with Q1 2026 EPS of $7.23 exceeding the $6.58 estimate. Revenue grew to $447.57 billion in 2025, though net income margin compressed to 2.68%. Recent news highlights strategic moves to reduce pediatric prior authorizations and shareholder-friendly actions like dividends and buybacks.
Outlook remains positive given analyst consensus (82.69% buy ratings) and a $430.94 price target, but risks include regulatory scrutiny from lawsuits and margin pressure. The stock offers stability through dividend growth and operational scale, though investors should monitor legal developments and healthcare policy changes.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About CDW Corp.
CDW Corp is a value-added reseller operating in the U.S. (95% of sales) and Canada (5%). The company has more than 100,000 products on its line of cards that range from notebooks to data center software. Roughly half of CDW's revenue comes from midsize and large businesses, with the remaining from small businesses, government agencies, education institutions, and health-care organizations.
Read more on CDW →About UnitedHealth Group Inc
UnitedHealth Group is one of the largest private health insurers, providing medical benefits to 50 million members globally, including 5 million outside the U.S. at the end of 2021. As a leader in employer-sponsored, self-directed, and government-backed insurance plans, UnitedHealth has obtained massive scale in managed care. Along with its insurance assets, UnitedHealth's continued investments in its Optum franchises have created a healthcare services colossus that spans everything from medical and pharmaceutical benefits to providing outpatient care and analytics to both affiliated and third-party customers.
Read more on UNH →
